Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

6,000

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

November 15, 2022

Study Completion Date

June 30, 2025

Conditions
Critical IllnessWounds and InjuryDisease AttributesPathologic Processes
Interventions
OTHER

Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg)

Post-implementation of targeted normoxemia through oxygen titration for individual patients. Interventions for treatment of hypoxemia will follow usual local practice. Interventions for treatment of hyperoxemia (SpO2 \>96% or PaO2 \>100 mmHg) will involve down titration of FiO2 (or supplemental oxygen for non-mechanically ventilated patients) within a time frame based on local site preferences-typically in increments of no greater than 0.10 until goal oxygenation in the normoxemia range is achieved (including room air \[no supplemental oxygen\] for non-mechanically ventilated patients).

Trial Locations (8)

15224

University of Pittsburgh Medical Center, Pittsburgh

35294

University of Alabama-Birmingham Medical Center, Birmingham

37232

Vanderbilt University Medical Center, Nashville

45219

University of Cincinnati Medical Center, Cincinnati

77030

The University of Texas Health Science Center at Houston, Houston

78234

Brooke Army Medical Center, Fort Sam Houston

80204

Denver Health, Denver

97239

Oregon Health and Sciences University, Portland

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

University of Colorado, Denver

OTHER

NCT04534959 - Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients | Biotech Hunter | Biotech Hunter